In addition, punctuate LC3 aggregates (the evidence of LC3 conversion) were observed after 3 kinds of HCC cells were treated with lapatinib (Fig. 4)[22]. The gene discussed is MAP1LC3A; the disease is hepatocellular carcinoma.